AOA-34 Annual Educational Conference

Intersect ENT 

Booth 402

Menlo Park,, CA  
      United States

Intersect ENT is an innovator in local drug delivery developing clinically proven therapy solutions to improve quality of life for patients with ENT conditions.  PROPEL® and PROPEL® mini dissolvable steroid-releasing implants are the only products backed by Level 1-A clinical evidence to improve surgical outcomes for chronic sinusitis sufferers. 

Product Categories